HLB Co., Ltd. (KOSDAQ:028300)
South Korea · Delayed Price · Currency is KRW 46,050
-500 (-1.07%)
At close: Dec 26, 2025
HLB Co., Ltd. Market Cap
HLB Co., Ltd. has a market cap or net worth of 6.06 trillion as of December 26, 2025. Its market cap has decreased by -37.21% in one year.
Market Cap
6.06T
Enterprise Value
6.26T
Revenue
80.73B
Ranking
n/a
PE Ratio
n/a
Stock Price
46,050.00
Market Cap Chart
Since December 24, 2008, HLB Co., Ltd.'s market cap has increased from 13.46B to 6.06T, an increase of 44,924.36%. That is a compound annual growth rate of 43.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 6.06T | -36.78% |
| Dec 30, 2024 | 9.59T | 46.53% |
| Dec 28, 2023 | 6.54T | 98.02% |
| Dec 29, 2022 | 3.30T | -10.84% |
| Dec 30, 2021 | 3.71T | -24.18% |
| Dec 30, 2020 | 4.89T | -0.25% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.28T |
| Celltrion | 39.82T |
| ALTEOGEN | 23.00T |
| ABL Bio | 10.34T |
| SK Biopharmaceuticals | 9.95T |
| Yuhan | 8.60T |
| LigaChem Biosciences | 6.28T |
| Hanmi Pharm. | 5.59T |